News Features Roughly 80% of ESC Guideline Writers Have Financial COIs Michael O'Riordan April 01, 2021
News Daily News CMS Extends MitraClip Coverage to Functional MR, Carves Out Imager Role Shelley Wood January 20, 2021
News Daily News ACC Issues New Guidance Around Antithrombotic Choices in A-fib, VTE Todd Neale December 22, 2020
News Daily News AHA: Advice on Lifestyle, Risk Factor Modification to Cut A-fib Events Yael L. Maxwell March 13, 2020
News Conference News STS 2020 Safer, Quicker Discharge With Protocols for Enhanced Recovery After Surgery Yael L. Maxwell February 07, 2020
News Daily News Apple Heart in Print: The Conversation on Data Privacy Continues Yael L. Maxwell November 15, 2019
News Daily News Late Follow-up of Surgical MV Repair: Insights for Timing, Innovation Shelley Wood August 20, 2019
News Features Wearables Under the Microscope: How New Tech Will Disrupt Patient-Physician Dynamics Marcus A. Banks August 15, 2019
News Daily News Bleeding, Myocardial Injury Are Key Drivers of Deaths After Noncardiac Surgery Michael O'Riordan July 29, 2019
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for May 2019 Caitlin E. Cox May 31, 2019
News Daily News AHA Warns of Stagnating CVD Gains, Barriers to Access, and Dismal Drug Pipeline Michael O'Riordan January 29, 2019
News Daily News ‘The Bleeding Edge’ Documentary, Tackling Medical Device Regulation, Spurs Diverse Cardiology Reactions Yael L. Maxwell August 17, 2018
News Daily News Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond Shelley Wood December 26, 2017
News Conference News AHA 2017 Circling Back on ORBITA: Sham-Controlled PCI Trial Makes Best of 2017 List Michael O'Riordan November 12, 2017
News Daily News Women With A-fib Less Likely to Get Oral Anticoagulants Regardless of Risk Leah Lawrence August 03, 2017
News Daily News Many Stroke Patients Stop Statins or Never Start, With Dire Consequences Michael O'Riordan August 02, 2017
News Conference News ACC 2017 ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More Shelley Wood March 10, 2017